AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pharmaceuticals	96.45M	143.53M	1.63M	1.44M
Pharmaceuticals Growth	-32.80%	8727.18%	13.31%	-
Total	96.45M	143.53M	1.63M	1.44M
Total Growth	-32.80%	8727.18%	13.31%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Taiwan	3.90M	587.00K	1.63M	1.44M
Taiwan Growth	565.08%	-63.90%	13.31%	-
USA	92.54M	142.94M	-	-
USA Growth	-35.26%	-	-	-
Total	96.45M	143.53M	1.63M	1.44M
Total Growth	-32.80%	8727.18%	13.31%	-

Source: S&P Global Market Intelligence.